Reach Out
  • Homepage
  • Meet the Team
  • Insights
Masavin
Pixivart
Masavin
  • Homepage
  • Meet the Team
  • Insights
© Copyright 2026

Merck Is Paying $588M for Potential Successor to Cancer Drug Juggernaut Keytruda

ArtemJuly 27, 2026
Cancer drug dealmaking is heating up around promising candidates with the potential to ... Read More

CEO of Otsuka North America: Are We Getting better access with AI?

ArtemJuly 20, 2026
Otsuka Pharmaceutical’s North American CEO —Tarek Rabah — has deep respect for all ... Read More

How One Optum Exec Is Handling the Influx of Digital Mental Health Solutions

ArtemJuly 17, 2026
Like many insurers, UnitedHealthcare and Optum are dealing with a surge in digital ... Read More

Lunit Partners with VIDI Group to Deliver AI-Powered Mammography to France’s Largest Radiology Network

ArtemJuly 15, 2026
What You Should Know: – Lunit, a leading provider of AI-powered cancer diagnostics ... Read More

AMA Issues CPT Code for Eko Health’s AI-Powered Cardiac Screening Tool

ArtemJuly 10, 2026
What You Should Know: – Eko Health, a pioneer in applying artificial intelligence for ... Read More

PTC Therapeutics Wins First FDA Approval for a Gene Therapy Dosed Directly Into the Brain

ArtemJuly 9, 2026
An ultra-rare enzyme deficiency that keeps infants from achieving proper muscle function among ... Read More

Posts pagination

1 2

Looking Back, Moving Forward: Your Year-End Reflection

July 18, 2026

Top 10 Board Games of 2024: What is Old is New Again

July 23, 2026

Surviving the Holidays: How to Avoid Social Burnout

July 26, 2026
Custom Menu(Copy)
  • Homepage
  • Insights
  • Meet the Team
  • Let’s Talk
Custom Menu
  • Privacy Policy
  • Terms and Conditions
Logo
  • [email protected]
  • (866) 574-3047